Pfizer Stock Holds Steady Despite Market Dip; Earnings Decline Expected

• Pfizer (PFE) stock outperformed market despite overall dip; closed at $25.91, up 0.19% • Pfizer slated to report earnings on May 1, 2024; expected to show 54.47% drop in EPS to $0.56 • Revenue forecasted to decline 24.57% to $13.79 billion • For full fiscal year, EPS predicted to rise 20.65% to $2.22; revenue to increase 2.56% to $59.99 billion • Pfizer trades at discount to pharmaceutical industry average; has PEG ratio of 1.16 vs sector average of 1.69